Roles of chondroitin sulfate and dermatan sulfate in the formation of a lesion scar and axonal regeneration after traumatic injury of the mouse brain

Journal of Neurotrauma

Volumn 30, Issue 5, 2013, Pages 413-425

  Li, Hong Peng ^a,b   Komuta, Yukari ^a   Kimura Kuroda, Junko ^a   Van Kuppevelt, Toin H ^c   Kawano, Hitoshi ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

axonal regeneration; extracellular matrix; glial response to injury; in vitro study; traumatic brain injury

Indexed keywords

CHONDROITIN ABC LYASE; CHONDROITIN AC LYASE; CHONDROITIN SULFATE; CHONDROITINASE B; COLLAGEN TYPE 4; DERMATAN SULFATE; GLIAL FIBRILLARY ACIDIC PROTEIN; N ACETYLGALACTOSAMINE 4 SULFATASE; TRANSFORMING GROWTH FACTOR BETA1; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CEREBELLUM; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; ENZYMATIC DEGRADATION; FIBROBLAST; FIBROSIS; GLIA; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; MALE; MOUSE; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NEWBORN; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCAR FORMATION; TRAUMATIC BRAIN INJURY;

ANIMALS; ASTROCYTES; AXONS; BRAIN INJURIES; CHONDROITIN SULFATES; CICATRIX; COCULTURE TECHNIQUES; DERMATAN SULFATE; DISEASE MODELS, ANIMAL; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED ICR; NERVE REGENERATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84874704840     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2012.2513     Document Type: Article

References (56)

1. Carulli, D., Laabs, T., Geller, H.M. and Fawcett, J.W. (2005). Chondroitin sulfate proteoglycans in neural development and regeneration. Curr. Opin. Neurobiol. 15, 116-120.
2. Fitch, M.T., and Silver, J. (2008). CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp. Neurol. 209, 294-301.
3. Morgenstern, D.A., Asher, R.A., and Fawcett, J.W. (2002). Chondroitin sulphate proteoglycans in the CNS injury response. Prog. Brain Res. 137, 313-332.
4. Silver, J., and Miller, J.H. (2004). Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5, 146-156.
5. Yiu, G., and He, Z. (2006). Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci. 7, 617-627.
6. Moon, L.D., Asher, R.A., Rhodes, K.E., and Fawcett, J.W. (2001). Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat. Neurosci. 4, 465-466.
7. Bradbury, E.J., Moon, L.D., Popat, R.J., King, V.R., Bennett, G.S., Patel, P.N., Fawcett, J.W., and McMahon, S.B. (2002). Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416, 636-640.
8. Kawano, H., Kimura-Kuroda, J., Komuta, Y., Yoshioka, N., Li, H.P., Kawamura, K., Li, Y. and Raisman, G. (2012). Role of the lesion scar in the response to damage and repair of the central nervous system. Cell Tissue Res. 349,169-180.
9. Stichel, C.C., Niermann, H., D'Urso, D., Lausberg, F., Hermanns, S., and Mu?ller, H.W. (1999). Basal membrane-depleted scar in lesioned CNS: characteristics and relationships with regenerating axons. Neuroscience 93, 321-333.
10. Kawano, H., Li, H.P., Sango, K., Kawamura, K., and Raisman, G. (2005). Inhibition of collagen synthesis overrides the age-related failure of regeneration of nigrostriatal dopaminergic axons. J. Neurosci. Res. 80, 191-202.
11. Teng, X., Nagata, I., Li, H.P., Kimura-Kuroda, J., Sango, K., Kawamura, K., Raisman, G., and Kawano, H. (2008). Regeneration of nigrostriatal dopaminergic axons after transplantation of olfactory ensheathing cells and fibroblasts prevents fibrotic scar formation at the lesion site. J. Neurosci. Res. 86, 3140-3150.
12. Li, H.P., Homma, A., Sango, K., Kawamura, K., Raisman, G., and Kawano, H. (2007). Regeneration of nigrostriatal dopaminergic axons by degradation of chondroitin sulfate is accompanied by elimination of the fibrotic scar and glia limitans in the lesion site. J. Neurosci. Res. 85, 536-547.
13. Trowbridge, J.M., and Gallo, R.L. (2002). Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology 12, 117R- 125R.
14. Koz'ma, E.M., Wisowski, G., Kusz, D., and Olczyk, K. (2011). The role of decorin and biglycan dermatan sulfate chain(s) in fibrosisaffected fascia. Glycobiology 21, 1301-1316.
15. Yamagata, T., Saito, H., Habuchi, O., and Suzuki, S. (1968). Purification and properties of bacterial chondroitinases and chondrosulfatases. J. Biol. Chem. 243, 1523-1535.
16. Michelacci, Y.M., and Dietrich, C.P. (1975). A comparative study between a chondroitinase B and a chondroitinase AC from Flavobacterium heparinum: isolation of a chondroitinase AC-susceptible dodecasaccharide from chondroitin sulphate B. Biochem. J. 151, 121-129.
17. Kimura-Kuroda, J., Teng, X., Komuta, Y., Yoshioka, N., Sango, K., Kawamura, K., Raisman, G., and Kawano, H. (2010). An in vitro model of the inhibition of axon growth in the lesion scar formed after central nervous system injury. Mol. Cell. Neurosci. 43, 177-187.
18. Yoshioka, N., Kimura-Kuroda, J., Saito, T., Kawamura, K., Hisanaga, S., and Kawano, H. (2011). Small molecule inhibitor of type I transforming growth factor-b receptor kinase ameliorates the inhibitory milieu in injured brain and promotes regeneration of nigrostriatal dopaminergic axons. J. Neurosci. Res. 89, 381-393.
19. Lensen, J.F., Wijnhoven, T.J., Kuik, L.H., Versteeg, E.M., Hafmans, T., Rops, A.L., Pavao, M.S., van der Vlag, J., van den Heuvel, L.P., Berden, J.H., and van Kuppevelt, T.H. (2006). Selection and characterization of a unique phage display-derived antibody against dermatan sulfate. Matrix Biol. 25, 457-461.
20. Kawano, H., Ohyama, K., Kawamura, K., and Nagatsu, I. (1995). Migration of dopaminergic neurons in the embryonic mesencephalon of mice. Brain Res. Dev. Brain Res. 86, 101-113.
21. Hierck, B.P., Iperen, L.V., Gittenberger-De Groot, A.C., and Poelmann, R.E. (1994). Modified indirect immunodetection allows study of murine tissue with mouse monoclonal antibodies. J. Histochem. Cytochem. 42:1499-1502.
22. Nagata, I., Ono, K., Kawana, A., and Kimura-Kuroda, J. (2006). Aligned neurite bundles of granule cells regulate orientation of Purkinje cell dendrites by perpendicular contact guidance in twodimensional and three-dimensional mouse cerebellar cultures. J. Comp. Neurol. 499, 274-289.
23. Logan, A., Green, J., Hunter, A., Jackson, R., and Berry, M. (1999). Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-beta2. Eur. J. Neurosci. 11, 2367-2374.
24. Komuta, Y., Teng, X., Yanagisawa, H., Sango, K., Kawamura, K., and Kawano, H. (2010). Expression of transforming growth factor-b receptors in meningeal fibroblasts of the injured mouse brain. Cell. Mol. Neurobiol. 30, 101-111.
25. Border, W.A., Okuda, S., Languino, L.R., and Ruoslahti, E. (1990). Transforming growth factor-beta regulates production of proteoglycans by mesangial cells. Kidney Int. 37, 689-695.
26. Romari's, M., Heredia, A., Molist, A., and Bassols, A. (1991). Differential effect of transforming growth factor beta on proteoglycan synthesis in human embryonic lung fibroblasts. Biochim. Biophys. Acta 1093, 229-233.
27. Westergren-Thorsson, G., Schmidtchen, A., Sa?rnstrand, B., Fransson, L.A., and Malmstro?m, A. (1992). Transforming growth factor-beta induces selective increase of proteoglycan production and changes in the copolymeric structure of dermatan sulphate in human skin fibroblasts. Eur. J. Biochem. 205, 277-286.
28. Shearer, M.C., and Fawcett, J.W. (2001). The astrocyte/meningeal cell interface - a barrier to successful nerve regeneration? Cell Tissue Res. 305, 267-273.
29. Denholm, E.M., Cauchon, E., Poulin, C., and Silver, P.J. (2000). Inhibition of human dermal fibroblast proliferation by removal of dermatan sulfate. Eur. J. Pharmacol. 400, 145-153.
30. Maccarana, M., Kalamajski, S., Kongsgaard, M., Magnusson, S.P., Oldberg, A., and Malmstro?m, A. (2009). Dermatan sulfate epimerase 1-deficient mice have reduced content and changed distribution of iduronic acids in dermatan sulfate and an altered collagen structure in skin. Mol. Cell Biol. 29, 5517-5528.
31. Stichel, C.C., Kappler, J., Junghans, U., Koops, A., Kresse, H., and Mu?ller, H.W. (1995). Differential expression of the small chondroitin/ dermatan sulfate proteoglycans decorin and biglycan after injury of the adult rat brain. Brain Res. 704, 263-274.
32. Asher, R.A., Morgenstern, D.A., Shearer, M.C., Adcock, K.H., Pesheva, P., and Fawcett, J.W. (2002). Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J. Neurosci. 22, 2225-2236.
33. Stylli, S.S., Kaye, A.H., and Novak, U. (2000). Induction of CD44 expression in stab wounds of the brain: long term persistence of CD44 expression. J. Clin. Neurosci. 7, 137-140.
34. Moon, C., Heo, S., Sim, K.B., and Shin, T. (2004). Upregulation of CD44 expression in the spinal cords of rats with clip compression injury. Neurosci. Lett. 367, 133-136.
35. Brown, T.A., Bouchard, T., St John, T., Wayner, E., and Carter, W.G. (1991). Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J. Cell Biol. 113, 207-221.
36. Iozzo, R.V. (1997). The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit. Rev. Biochem. Mol. Biol. 32, 141-174.
37. Reed, C.C., and Iozzo, R.V. (2002). The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj. J. 19, 249-255.
38. Ja?rvela?inen, H., Puolakkainen, P., Pakkanen, S., Brown, E.L., Ho?o?k, M., Iozzo, R.V., Sage, E.H., and Wight, T.N. (2006). A role for decorin in cutaneous wound healing and angiogenesis. Wound Repair Regen. 14, 443-452.
39. Clark, R.A., Lin, F., Greiling, D., An, J., and Couchman, J.R. (2004). Fibroblast invasive migration into fibronectin/fibrin gels requires a previously uncharacterized dermatan sulfate-CD44 proteoglycan. J. Invest. Dermatol. 122, 266-277.
40. Huebener, P., Abou-Khamis, T., Zymek, P., Bujak, M., Ying, X., Chatila, K., Haudek, S., Thakker, G., and Frangogiannis, N.G. (2008). CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response. J. Immunol. 180, 2625-2633.
41. Yoshioka, N., Hisanaga, S., and Kawano, H. (2010). Suppression of fibrotic scar formation promotes axonal regeneration without disturbing blood-brain barrier repair and withdrawal of leukocytes after traumatic brain injury. J. Comp. Neurol. 518, 3867-3881.
42. Logan, A., Baird, A., and Berry, M. (1999). Decorin attenuates gliotic scar formation in the rat cerebral hemisphere. Exp. Neurol. 159, 504-510.
43. Moon, L.D., and Fawcett, J.W. (2001). Reduction in CNS scar formation without concomitant increase in axon regeneration following treatment of adult rat brain with a combination of antibodies to TGFbeta1 and beta2. Eur. J. Neurosci, 14, 1667-1677.
44. Wang, Y., Moges, H., Bharucha, Y., and Symes, A. (2007). Smad3 null mice display more rapid wound closure and reduced scar formation after a stab wound to the cerebral cortex. Exp. Neurol. 203, 168-184.
45. Hamel, M.G., Mayer, J., and Gottschall, P.E. (2005). Altered production and proteolytic processing of brevican by transforming growth factor beta in cultured astrocytes. J. Neurochem. 93, 1533-1541.
46. Susarla, B.T., Laing, E.D., Yu, P., Katagiri, Y., Geller, H.M., and Symes, A.J. (2011). Smad proteins differentially regulate transforming growth factor-b-mediated induction of chondroitin sulfate proteoglycans. J. Neurochem. 119, 868-878.
47. Camand, E., Morel, M.P., Faissner, A., Sotelo, C., and Dusart, I. (2004). Long-term changes in the molecular composition of the glial scar and progressive increase of serotoninergic fibre sprouting after hemisection of the mouse spinal cord. Eur. J. Neurosci. 20, 1161- 1176.
48. Lafont, F., Rouget, M., Triller, A., Prochiantz, A., and Rousselet, A. (1992). In vitro control of neuronal polarity by glycosaminoglycans. Development 114, 17-29.
49. Faissner, A., Clement, A., Lochter, A., Streit, A., Mandl, C., and Schachner, M. (1994). Isolation of a neural chondroitin sulfate proteoglycan with neurite outgrowth promoting properties. J. Cell Biol. 126, 783-799.
50. Hikino, M., Mikami, T., Faissner, A., Vilela-Silva, A.C., Pava?o, M.S., and Sugahara, K. (2003). Oversulfated dermatan sulfate exhibits neurite outgrowth-promoting activity toward embryonic mouse hippocampal neurons: implications of dermatan sulfate in neuritogenesis in the brain. J. Biol. Chem. 278, 43744-43754.
51. Nandini, C.D., Itoh, N., and Sugahara, K. (2005). Novel 70-kDa chondroitin sulfate/dermatan sulfate hybrid chains with a unique heterogeneous sulfation pattern from shark skin, which exhibit neuritogenic activity and binding activities for growth factors and neurotrophic factors. J. Biol. Chem. 280, 4058-4069.
52. Verna, J.M., Fichard, A., and Saxod, R. (1989). Influence of glycosaminoglycans on neurite morphology and outgrowth patterns in vitro. Int. J. Dev. Neurosci. 7, 389-399.
53. Bao, X., Nishimura, S., Mikami, T., Yamada, S., Itoh, N., and Sugahara, K. (2004). Chondroitin sulfate/dermatan sulfate hybrid chains from embryonic pig brain, which contain a higher proportion of Liduronic acid than those from adult pig brain, exhibit neuritogenic and growth factor binding activities. J. Biol. Chem. 279, 9765-9776.
54. Li, F., Shetty, A.K., and Sugahara, K. (2007). Neuritogenic activity of chondroitin/dermatan sulfate hybrid chains of embryonic pig brain and their mimicry from shark liver. Involvement of the pleiotrophin and hepatocyte growth factor signaling pathways. J. Biol. Chem. 282, 2956-2966.
55. Hashiguchi, T., Mizumoto, S., Yamada, S., and Sugahara, K. (2010). Analysis of the structure and neuritogenic activity of chondroitin sulfate/dermatan sulfate hybrid chains from porcine fetal membranes. Glycoconj. J. 27, 49-60.
56. Zuo, J., Neubauer, D., Dyess, K., Ferguson, T.A., and Muir, D. (1998). Degradation of chondroitin sulfate proteoglycan enhances the neurite-promoting potential of spinal cord tissue. Exp. Neurol. 154, 654-662.